English

SALIX PHARMACEUTICALS LTD

EDGAR

SLXP Annual report amendment (10-K/A) · filed 2015-03-02

87 filing records in this dataset, filed from 1997-12-08 to 2015-03-02. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.5 million USD

2014 Q4 · USD

Exact inputs and evidence

Revenue: 13477000 USD Source

Operating margin

-3,141.95%

2014 Q4 · %

Exact inputs and evidence

Operating Income: -490097000 USD Source
Operating Income: -66656000 USD Source
Revenue: 13477000 USD Source

Operating cash flow

152 million USD

2014 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 4150000 USD Source
Operating Cash Flow: -147425000 USD Source

Free cash flow

147 million USD

2014 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 4150000 USD Source
Operating Cash Flow: -147425000 USD Source
Capital Expenditure: 17762000 USD Source
Capital Expenditure: 13376000 USD Source

Cash and cash equivalents: 499 million USD 2014-12-31 Source
Exact value

499339000 USD
Long-term debt including current maturities: 2.29 billion USD 2014-12-31 Source
Exact value

2290217000 USD
Shares outstanding: 63.8 million shares 2014-12-31 Source
Exact value

63826685 shares

Reported share-count change

1.41% · 889 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

62937966 shares · 2013-12-31· Source
63826685 shares · 2014-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-03-02.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2014-12-31
Operating income: 10 of 11 periods available· newest 2014-12-31
Net income: 10 of 11 periods available· newest 2014-12-31
Operating cash flow: 10 of 11 periods available· newest 2014-12-31
Capital expenditure: 10 of 11 periods available· newest 2014-12-31
Total assets: 10 of 11 periods available· newest 2014-12-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2014-12-31
Current liabilities: 10 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2014-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2014-12-31
Shares outstanding: 4 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+24%

Prior period

USD 913.78 million

2013-01-01 – 2013-12-31
Current period

USD 1.13 billion

2014-01-01 – 2014-12-31

Exact inputs and evidence

1133542000 − 913781000 = 219761000 USD

913781000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
1133542000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Year-over-year change in Revenue: 219761000 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1133542000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#247277 Filing: 000156459015001199 Input fundies:Revenue: 913781000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#247422 Filing: 000156459015001199
The citation records this snapshot. The page link may show a newer release later.
Net income
-417.2%

Prior period

USD 130.81 million

2013-01-01 – 2013-12-31
Current period

−USD 414.91 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-414911000 − 130811000 = -545722000 USD

130811000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-414911000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Year-over-year change in Net income: -545722000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -414911000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#254834 Filing: 000156459015001199 Input fundies:NetIncome: 130811000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#254989 Filing: 000156459015001199
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-99%

Prior period

USD 415.86 million

2013-01-01 – 2013-12-31
Current period

USD 4.15 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

4150000 − 415855000 = -411705000 USD

415855000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
4150000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Year-over-year change in Operating cash flow: -411705000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 4150000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288568 Filing: 000156459015001199 Input fundies:OperatingCashFlow: 415855000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288778 Filing: 000156459015001199
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+156.1%

Prior period

USD 6.94 million

2013-01-01 – 2013-12-31
Current period

USD 17.76 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

17762000 − 6936000 = 10826000 USD

6936000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
17762000 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Year-over-year change in Capital expenditure: 10826000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 17762000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289201 Filing: 000156459015001199 Input fundies:CapitalExpenditure: 6936000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289412 Filing: 000156459015001199
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 1.13 billion 100% of revenue
Cost of revenue USD 337.84 million 30% of revenue
Operating expenses USD 830.4 million 73% of revenue
Other operating costs Derived USD 455.4 million 40% of revenue
Operating income −USD 490.1 million −43% of revenue
Tax, interest and other Derived −USD 75.19 million −6.6% of revenue
Net income −USD 414.91 million −37% of revenue

Cash

Operating cash flow USD 4.15 million 0.4% of revenue
Capital expenditure USD 17.76 million 1.6% of revenue
Free cash flow Derived −USD 13.61 million −1.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Net income was higher than operating income, so the split is not drawn.
2005 Operating loss: operating costs were 139% of revenue.
2006 Net income was higher than operating income, so the split is not drawn.
2007 95%
2008 Operating loss: operating costs were 126% of revenue.
2010 Operating loss: operating costs were 102% of revenue.
2011 16%79%
2012 15%77%
2013 14%13%72%
2014 Operating loss: operating costs were 143% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	105496000	98847000 Derived	6649000	-190000 Derived	6839000	-5398000 Derived	Source 2004-01-01 – 2004-12-31: 105496000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 6649000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 6839000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -5019000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 379000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	154903000	215971000 Derived	-61068000	-483000 Derived	-60585000	613000 Derived	Source 2005-01-01 – 2005-12-31: 154903000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -61068000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -60585000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 3024000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2411000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	208533000	178199000 Derived	30334000	-1176000 Derived	31510000	16194000 Derived	Source 2006-01-01 – 2006-12-31: 208533000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 30334000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 31510000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 17894000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 1700000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	235792000	223940000 Derived	11852000	3627000 Derived	8225000	73785000 Derived	Source 2007-01-01 – 2007-12-31: 235792000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 11852000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 8225000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 76153000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 2368000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	178766000	225424000 Derived	-46658000	949000 Derived	-47607000	-21739000 Derived	Source 2008-01-01 – 2008-12-31: 178766000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -46658000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -47607000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -20883000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 856000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	336973000	343150000 Derived	-6177000	20884000 Derived	-27061000	19946000 Derived	Source 2010-01-01 – 2010-12-31: 336973000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -6177000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -27061000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 25518000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 5572000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	540488000	424615000 Derived	115873000	28474000 Derived	87399000	93011000 Derived	Source 2011-01-01 – 2011-12-31: 540488000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 115873000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: 87399000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: 119150000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 26139000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	735444000	563371000 Derived	172073000	107827000 Derived	64246000	82222000 Derived	Source 2012-01-01 – 2012-12-31: 735444000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: 172073000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 64246000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: 87592000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 5370000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	913781000	661470000 Derived	252311000	121500000 Derived	130811000	408919000 Derived	Source 2013-01-01 – 2013-12-31: 913781000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 252311000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 130811000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 415855000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 6936000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	1133542000	1623639000 Derived	-490097000	-75186000 Derived	-414911000	-13612000 Derived	Source 2014-01-01 – 2014-12-31: 1133542000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -490097000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -414911000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 4150000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 17762000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.1B 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	105496000	Revenue: 105496000 Open source
20052005-12-31	Revenue	154903000	Revenue: 154903000 Open source
20062006-12-31	Revenue	208533000	Revenue: 208533000 Open source
20072007-12-31	Revenue	235792000	Revenue: 235792000 Open source
20082008-12-31	Revenue	178766000	Revenue: 178766000 Open source
20102010-12-31	Revenue	336973000	Revenue: 336973000 Open source
20112011-12-31	Revenue	540488000	Revenue: 540488000 Open source
20122012-12-31	Revenue	735444000	Revenue: 735444000 Open source
20132013-12-31	Revenue	913781000	Revenue: 913781000 Open source
20142014-12-31	Revenue	1133542000	Revenue: 1133542000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

24% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 105496000 Open source
20052005-12-31	Year over year	46.8%	Revenue: 154903000 Open source Revenue: 105496000 Open source
20062006-12-31	Year over year	34.6%	Revenue: 208533000 Open source Revenue: 154903000 Open source
20072007-12-31	Year over year	13.1%	Revenue: 235792000 Open source Revenue: 208533000 Open source
20082008-12-31	Year over year	-24.2%	Revenue: 178766000 Open source Revenue: 235792000 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 336973000 Open source
20112011-12-31	Year over year	60.4%	Revenue: 540488000 Open source Revenue: 336973000 Open source
20122012-12-31	Year over year	36.1%	Revenue: 735444000 Open source Revenue: 540488000 Open source
20132013-12-31	Year over year	24.2%	Revenue: 913781000 Open source Revenue: 735444000 Open source
20142014-12-31	Year over year	24%	Revenue: 1133542000 Open source Revenue: 913781000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -43.2% 2014

Net margin -36.6% 2014

Free cash flow margin -1.2% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	6.3%	Operating Income: 6649000 Open source Revenue: 105496000 Open source
20052005-12-31	Operating margin	-39.4%	Operating Income: -61068000 Open source Revenue: 154903000 Open source
20062006-12-31	Operating margin	14.5%	Operating Income: 30334000 Open source Revenue: 208533000 Open source
20072007-12-31	Operating margin	5%	Operating Income: 11852000 Open source Revenue: 235792000 Open source
20082008-12-31	Operating margin	-26.1%	Operating Income: -46658000 Open source Revenue: 178766000 Open source
20102010-12-31	Operating margin	-1.8%	Operating Income: -6177000 Open source Revenue: 336973000 Open source
20112011-12-31	Operating margin	21.4%	Operating Income: 115873000 Open source Revenue: 540488000 Open source
20122012-12-31	Operating margin	23.4%	Operating Income: 172073000 Open source Revenue: 735444000 Open source
20132013-12-31	Operating margin	27.6%	Operating Income: 252311000 Open source Revenue: 913781000 Open source
20142014-12-31	Operating margin	-43.2%	Operating Income: -490097000 Open source Revenue: 1133542000 Open source
20042004-12-31	Net margin	6.5%	Net Income: 6839000 Open source Revenue: 105496000 Open source
20052005-12-31	Net margin	-39.1%	Net Income: -60585000 Open source Revenue: 154903000 Open source
20062006-12-31	Net margin	15.1%	Net Income: 31510000 Open source Revenue: 208533000 Open source
20072007-12-31	Net margin	3.5%	Net Income: 8225000 Open source Revenue: 235792000 Open source
20082008-12-31	Net margin	-26.6%	Net Income: -47607000 Open source Revenue: 178766000 Open source
20102010-12-31	Net margin	-8%	Net Income: -27061000 Open source Revenue: 336973000 Open source
20112011-12-31	Net margin	16.2%	Net Income: 87399000 Open source Revenue: 540488000 Open source
20122012-12-31	Net margin	8.7%	Net Income: 64246000 Open source Revenue: 735444000 Open source
20132013-12-31	Net margin	14.3%	Net Income: 130811000 Open source Revenue: 913781000 Open source
20142014-12-31	Net margin	-36.6%	Net Income: -414911000 Open source Revenue: 1133542000 Open source
20042004-12-31	Free cash flow margin	-5.1%	Revenue: 105496000 Open source Operating Cash Flow: -5019000 Open source Capital Expenditure: 379000 Open source
20052005-12-31	Free cash flow margin	0.4%	Revenue: 154903000 Open source Operating Cash Flow: 3024000 Open source Capital Expenditure: 2411000 Open source
20062006-12-31	Free cash flow margin	7.8%	Revenue: 208533000 Open source Operating Cash Flow: 17894000 Open source Capital Expenditure: 1700000 Open source
20072007-12-31	Free cash flow margin	31.3%	Revenue: 235792000 Open source Operating Cash Flow: 76153000 Open source Capital Expenditure: 2368000 Open source
20082008-12-31	Free cash flow margin	-12.2%	Revenue: 178766000 Open source Operating Cash Flow: -20883000 Open source Capital Expenditure: 856000 Open source
20102010-12-31	Free cash flow margin	5.9%	Revenue: 336973000 Open source Operating Cash Flow: 25518000 Open source Capital Expenditure: 5572000 Open source
20112011-12-31	Free cash flow margin	17.2%	Revenue: 540488000 Open source Operating Cash Flow: 119150000 Open source Capital Expenditure: 26139000 Open source
20122012-12-31	Free cash flow margin	11.2%	Revenue: 735444000 Open source Operating Cash Flow: 87592000 Open source Capital Expenditure: 5370000 Open source
20132013-12-31	Free cash flow margin	44.8%	Revenue: 913781000 Open source Operating Cash Flow: 415855000 Open source Capital Expenditure: 6936000 Open source
20142014-12-31	Free cash flow margin	-1.2%	Revenue: 1133542000 Open source Operating Cash Flow: 4150000 Open source Capital Expenditure: 17762000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 4.2M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-5019000	Operating Cash Flow: -5019000 Open source
20052005-12-31	Operating cash flow	3024000	Operating Cash Flow: 3024000 Open source
20062006-12-31	Operating cash flow	17894000	Operating Cash Flow: 17894000 Open source
20072007-12-31	Operating cash flow	76153000	Operating Cash Flow: 76153000 Open source
20082008-12-31	Operating cash flow	-20883000	Operating Cash Flow: -20883000 Open source
20102010-12-31	Operating cash flow	25518000	Operating Cash Flow: 25518000 Open source
20112011-12-31	Operating cash flow	119150000	Operating Cash Flow: 119150000 Open source
20122012-12-31	Operating cash flow	87592000	Operating Cash Flow: 87592000 Open source
20132013-12-31	Operating cash flow	415855000	Operating Cash Flow: 415855000 Open source
20142014-12-31	Operating cash flow	4150000	Operating Cash Flow: 4150000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.6M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	-5398000	Operating Cash Flow: -5019000 Open source Capital Expenditure: 379000 Open source
20052005-12-31	Free cash flow	613000	Operating Cash Flow: 3024000 Open source Capital Expenditure: 2411000 Open source
20062006-12-31	Free cash flow	16194000	Operating Cash Flow: 17894000 Open source Capital Expenditure: 1700000 Open source
20072007-12-31	Free cash flow	73785000	Operating Cash Flow: 76153000 Open source Capital Expenditure: 2368000 Open source
20082008-12-31	Free cash flow	-21739000	Operating Cash Flow: -20883000 Open source Capital Expenditure: 856000 Open source
20102010-12-31	Free cash flow	19946000	Operating Cash Flow: 25518000 Open source Capital Expenditure: 5572000 Open source
20112011-12-31	Free cash flow	93011000	Operating Cash Flow: 119150000 Open source Capital Expenditure: 26139000 Open source
20122012-12-31	Free cash flow	82222000	Operating Cash Flow: 87592000 Open source Capital Expenditure: 5370000 Open source
20132013-12-31	Free cash flow	408919000	Operating Cash Flow: 415855000 Open source Capital Expenditure: 6936000 Open source
20142014-12-31	Free cash flow	-13612000	Operating Cash Flow: 4150000 Open source Capital Expenditure: 17762000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	Total Assets: 107864000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 282472000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 323123000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 397102000 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 400484000 Open source
2010-12-31	Liabilities / assets	Not reported	No source recorded
2011-12-31	Liabilities / assets	Not reported	Total Assets: 1304255000 Open source
2012-12-31	Liabilities / assets	Not reported	Total Assets: 1874784000 Open source
2013-12-31	Liabilities / assets	Not reported	Total Assets: 2925951000 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 4117343000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.68× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	4.3×	Current Assets: 91091000 Open source Current Liabilities: 21177000 Open source
20052005-12-31	Current assets / current liabilities	3.24×	Current Assets: 136779000 Open source Current Liabilities: 42259000 Open source
20062006-12-31	Current assets / current liabilities	3.78×	Current Assets: 170125000 Open source Current Liabilities: 44980000 Open source
20072007-12-31	Current assets / current liabilities	2.26×	Current Assets: 195375000 Open source Current Liabilities: 86484000 Open source
20082008-12-31	Current assets / current liabilities	2.57×	Current Assets: 186220000 Open source Current Liabilities: 72425000 Open source
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	2.69×	Current Assets: 567095000 Open source Current Liabilities: 210645000 Open source
20122012-12-31	Current assets / current liabilities	4.56×	Current Assets: 1188581000 Open source Current Liabilities: 260920000 Open source
20132013-12-31	Current assets / current liabilities	5.47×	Current Assets: 2282669000 Open source Current Liabilities: 417237000 Open source
20142014-12-31	Current assets / current liabilities	0.68×	Current Assets: 1005959000 Open source Current Liabilities: 1475275000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	USD 6.84 million Exact value Exact value: 6839000 USD 2004-01-01 – 2004-12-31: 6839000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2004-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 6839000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6839000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-07-055440.txt#6187 The citation records this snapshot. The page link may show a newer release later.	−USD 5.02 million Exact value Exact value: -5019000 USD 2004-01-01 – 2004-12-31: -5019000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2004-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: -5019000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5019000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-07-055440.txt#6369 The citation records this snapshot. The page link may show a newer release later.	USD 379,000 Exact value Exact value: 379000 USD 2004-01-01 – 2004-12-31: 379000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2004-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 379000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 379000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-07-055440.txt#6397 The citation records this snapshot. The page link may show a newer release later.	−USD 5.4 million Calculation and evidence -5019000 − 379000 USD Exact free cash flow: -5398000 USD 2004-01-01 – 2004-12-31: -5019000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 379000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2004-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: -5398000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5019000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-07-055440.txt#6369 Input fundies:CapitalExpenditure: 379000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-07-055440.txt#6397 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 60.59 million Exact value Exact value: -60585000 USD 2005-01-01 – 2005-12-31: -60585000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2005-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: -60585000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -60585000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-08-059815.txt#7135 The citation records this snapshot. The page link may show a newer release later.	USD 3.02 million Exact value Exact value: 3024000 USD 2005-01-01 – 2005-12-31: 3024000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2005-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 3024000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3024000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-08-059815.txt#7317 The citation records this snapshot. The page link may show a newer release later.	USD 2.41 million Exact value Exact value: 2411000 USD 2005-01-01 – 2005-12-31: 2411000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2005-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 2411000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2411000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-08-059815.txt#7345 The citation records this snapshot. The page link may show a newer release later.	USD 613,000 Calculation and evidence 3024000 − 2411000 USD Exact free cash flow: 613000 USD 2005-01-01 – 2005-12-31: 3024000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2411000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2005-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 613000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3024000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-08-059815.txt#7317 Input fundies:CapitalExpenditure: 2411000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-08-059815.txt#7345 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 31.51 million Exact value Exact value: 31510000 USD 2006-01-01 – 2006-12-31: 31510000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2006-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 31510000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 31510000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-09-050766.txt#7739 The citation records this snapshot. The page link may show a newer release later.	USD 17.89 million Exact value Exact value: 17894000 USD 2006-01-01 – 2006-12-31: 17894000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2006-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 17894000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 17894000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-09-050766.txt#7907 The citation records this snapshot. The page link may show a newer release later.	USD 1.7 million Exact value Exact value: 1700000 USD 2006-01-01 – 2006-12-31: 1700000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2006-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 1700000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1700000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-09-050766.txt#7935 The citation records this snapshot. The page link may show a newer release later.	USD 16.19 million Calculation and evidence 17894000 − 1700000 USD Exact free cash flow: 16194000 USD 2006-01-01 – 2006-12-31: 17894000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 1700000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2006-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 16194000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 17894000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-09-050766.txt#7907 Input fundies:CapitalExpenditure: 1700000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-09-050766.txt#7935 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 8.23 million Exact value Exact value: 8225000 USD 2007-01-01 – 2007-12-31: 8225000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2007-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 8225000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8225000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-10-051570.txt#7802 The citation records this snapshot. The page link may show a newer release later.	USD 76.15 million Exact value Exact value: 76153000 USD 2007-01-01 – 2007-12-31: 76153000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2007-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 76153000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 76153000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-10-051570.txt#7970 The citation records this snapshot. The page link may show a newer release later.	USD 2.37 million Exact value Exact value: 2368000 USD 2007-01-01 – 2007-12-31: 2368000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2007-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 2368000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2368000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-10-051570.txt#7998 The citation records this snapshot. The page link may show a newer release later.	USD 73.79 million Calculation and evidence 76153000 − 2368000 USD Exact free cash flow: 73785000 USD 2007-01-01 – 2007-12-31: 76153000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 2368000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2007-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 73785000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 76153000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-10-051570.txt#7970 Input fundies:CapitalExpenditure: 2368000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-10-051570.txt#7998 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 47.61 million Exact value Exact value: -47607000 USD 2008-01-01 – 2008-12-31: -47607000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2008-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: -47607000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47607000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-11-051490.txt#9481 The citation records this snapshot. The page link may show a newer release later.	−USD 20.88 million Exact value Exact value: -20883000 USD 2008-01-01 – 2008-12-31: -20883000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2008-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: -20883000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20883000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-11-051490.txt#9649 The citation records this snapshot. The page link may show a newer release later.	USD 856,000 Exact value Exact value: 856000 USD 2008-01-01 – 2008-12-31: 856000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2008-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 856000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 856000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-11-051490.txt#9677 The citation records this snapshot. The page link may show a newer release later.	−USD 21.74 million Calculation and evidence -20883000 − 856000 USD Exact free cash flow: -21739000 USD 2008-01-01 – 2008-12-31: -20883000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 856000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2008-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: -21739000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20883000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-11-051490.txt#9649 Input fundies:CapitalExpenditure: 856000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/0001193125-11-051490.txt#9677 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 27.06 million Exact value Exact value: -27061000 USD 2010-01-01 – 2010-12-31: -27061000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2010-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: -27061000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27061000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312513085041/slxp-20121231.xml#155352 Filing: 000119312513085041 The citation records this snapshot. The page link may show a newer release later.	USD 25.52 million Exact value Exact value: 25518000 USD 2010-01-01 – 2010-12-31: 25518000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2010-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 25518000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25518000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312513085041/slxp-20121231.xml#145807 Filing: 000119312513085041 The citation records this snapshot. The page link may show a newer release later.	USD 5.57 million Exact value Exact value: 5572000 USD 2010-01-01 – 2010-12-31: 5572000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2010-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 5572000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5572000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312513085041/slxp-20121231.xml#146806 Filing: 000119312513085041 The citation records this snapshot. The page link may show a newer release later.	USD 19.95 million Calculation and evidence 25518000 − 5572000 USD Exact free cash flow: 19946000 USD 2010-01-01 – 2010-12-31: 25518000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 5572000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2010-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 19946000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25518000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312513085041/slxp-20121231.xml#145807 Filing: 000119312513085041 Input fundies:CapitalExpenditure: 5572000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312513085041/slxp-20121231.xml#146806 Filing: 000119312513085041 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 87.4 million Exact value Exact value: 87399000 USD 2011-01-01 – 2011-12-31: 87399000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2011-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 87399000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 87399000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312515073225/slxp-20131231.xml#158163 Filing: 000119312515073225 The citation records this snapshot. The page link may show a newer release later.	USD 119.15 million Exact value Exact value: 119150000 USD 2011-01-01 – 2011-12-31: 119150000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2011-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 119150000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 119150000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312515073225/slxp-20131231.xml#152182 Filing: 000119312515073225 The citation records this snapshot. The page link may show a newer release later.	USD 26.14 million Exact value Exact value: 26139000 USD 2011-01-01 – 2011-12-31: 26139000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2011-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 26139000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26139000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312515073225/slxp-20131231.xml#153366 Filing: 000119312515073225 The citation records this snapshot. The page link may show a newer release later.	USD 93.01 million Calculation and evidence 119150000 − 26139000 USD Exact free cash flow: 93011000 USD 2011-01-01 – 2011-12-31: 119150000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 26139000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2011-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 93011000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 119150000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312515073225/slxp-20131231.xml#152182 Filing: 000119312515073225 Input fundies:CapitalExpenditure: 26139000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000119312515073225/slxp-20131231.xml#153366 Filing: 000119312515073225 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 64.25 million Exact value Exact value: 64246000 USD 2012-01-01 – 2012-12-31: 64246000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2012-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 64246000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 64246000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#255143 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 87.59 million Exact value Exact value: 87592000 USD 2012-01-01 – 2012-12-31: 87592000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2012-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 87592000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 87592000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288990 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 5.37 million Exact value Exact value: 5370000 USD 2012-01-01 – 2012-12-31: 5370000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2012-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 5370000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5370000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289622 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 82.22 million Calculation and evidence 87592000 − 5370000 USD Exact free cash flow: 82222000 USD 2012-01-01 – 2012-12-31: 87592000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 5370000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2012-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 82222000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 87592000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288990 Filing: 000156459015001199 Input fundies:CapitalExpenditure: 5370000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289622 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 130.81 million Exact value Exact value: 130811000 USD 2013-01-01 – 2013-12-31: 130811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2013-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: 130811000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 130811000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#254989 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 415.86 million Exact value Exact value: 415855000 USD 2013-01-01 – 2013-12-31: 415855000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2013-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 415855000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 415855000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288778 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 6.94 million Exact value Exact value: 6936000 USD 2013-01-01 – 2013-12-31: 6936000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2013-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 6936000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6936000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289412 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 408.92 million Calculation and evidence 415855000 − 6936000 USD Exact free cash flow: 408919000 USD 2013-01-01 – 2013-12-31: 415855000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 6936000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2013-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: 408919000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 415855000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288778 Filing: 000156459015001199 Input fundies:CapitalExpenditure: 6936000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289412 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 414.91 million Exact value Exact value: -414911000 USD 2014-01-01 – 2014-12-31: -414911000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Net Income: -414911000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -414911000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#254834 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 4.15 million Exact value Exact value: 4150000 USD 2014-01-01 – 2014-12-31: 4150000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Operating Cash Flow: 4150000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4150000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288568 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	USD 17.76 million Exact value Exact value: 17762000 USD 2014-01-01 – 2014-12-31: 17762000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Capital Expenditure: 17762000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17762000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289201 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.	−USD 13.61 million Calculation and evidence 4150000 − 17762000 USD Exact free cash flow: -13612000 USD 2014-01-01 – 2014-12-31: 4150000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 17762000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SALIX PHARMACEUTICALS LTD · 2014-12-31 SALIX PHARMACEUTICALS LTD (edgar:1009356) Free cash flow: -13612000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:50:00Z Snapshot: 5f5da76d491b3e8b510323485790a481de69e02f6e1c4f0ce4fcab5f868cbdbd Dimensions: Consolidated View: https://fundies.io/companies/edgar/1009356?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4150000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#288568 Filing: 000156459015001199 Input fundies:CapitalExpenditure: 17762000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1009356/000156459015001199/slxp-20141231.xml#289201 Filing: 000156459015001199 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

87 filings · 2,305 latest values · 2,305 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001009356, 1009356, SLXP, edgar:1009356

Also known as SALIX HOLDINGS LTD, SALIX PHARMACEUTICALS LTD

SALIX PHARMACEUTICALS LTD

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation